Fortrea Inc.

8.79
0.02 (0.23%)
At close: Mar 21, 2025, 3:59 PM
8.93
1.64%
After-hours: Mar 21, 2025, 06:38 PM EDT
0.23%
Bid 8.6
Market Cap 792.41M
Revenue (ttm) 2.72B
Net Income (ttm) -308.03M
EPS (ttm) -3.03
PE Ratio (ttm) -2.9
Forward PE 13.26
Analyst Hold
Ask 9.45
Volume 1,993,294
Avg. Volume (20D) 1,528,579
Open 8.68
Previous Close 8.77
Day's Range 8.65 - 8.94
52-Week Range 8.65 - 40.63
Beta 1.32

About FTRE

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to...

Industry Biotechnology
Sector Healthcare
IPO Date Jun 20, 2023
Employees 15,500
Stock Exchange NASDAQ
Ticker Symbol FTRE
Full Company Profile

Analyst Forecast

According to 11 analyst ratings, the average rating for FTRE stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 150.43% from the latest price.

Stock Forecasts

Next Earnings Release

Fortrea Inc. is scheduled to release its earnings on May 12, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-25.05%
Fortrea shares are trading lower after the company... Unlock content with Pro Subscription
3 months ago
-8.06%
Fortrea shares are trading lower after Baird downgraded the stock from Outperform to Neutral and cut its price target from $28 to $25.